The effect of Pulmozyme® and DNase I on the viability of B16 melanoma cells is shown in Figure 1A. Pulmozyme® in the concentration range of 0.1–0.5 × 103 U/mL only slightly decreases the viability of B16 cells, which amounted to 90–100%. This evidence concerns the gene DNASE1 and melanoma.